Robert V. Gunderson's most recent trade in Andersen Group Inc. - Ordinary Shares- Class A was a trade of 12,633 Class A Common Stock done at an average price of $16 . Disclosure was reported to the exchange on Dec. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Andersen Group Inc Ordinary | Robert V. Gunderson | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 18 Dec 2025 | 12,633 | 12,633 | - | 16 | 202,128 | Class A Common Stock |
| Theravance Biopharma Inc | Robert V. Gunderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 9,828 | 68,093 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Robert V. Gunderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 6,000 | 6,000 | - | - | Share Option (Right to Buy) |